神經再生療法市場：按神經再生療法類型、適應症、給藥方法、年齡層、最終用戶和地區分類。

預計到2026年，神經再生療法市場規模將達到166.5億美元，到2033年將達到384.4億美元。預計從2026年到2033年，該市場將以12.7%的複合年成長率成長。

神經再生是指神經組織（包括神經元、軸突、突觸和神經膠質細胞）的再生或修復過程。這個過程對於組織損傷後的修復以及確保長期功能恢復至關重要。它涉及新神經元和神經迴路的合成，從而提供額外的資源來補償受損區域。神經再生不僅是一種物理恢復機制，也是維持認知功能的重要機制。它在改善記憶障礙和老齡化相關異常方面發揮關鍵作用。透過藥物刺激神經再生，可以恢復認知功能，進而改善記憶力和其他認知能力。簡而言之，神經再生是一個至關重要的生物學過程，對各種神經系統疾病的治療和促進大腦健康有重大影響。

市場動態：

受以下幾個關鍵因素的驅動，全球神經再生療法市場預計在未來幾年將迎來顯著成長。首先，包括中樞和周邊神經系統疾病在內的神經系統疾病盛行率不斷上升，推動了對有效且安全療法的更大需求。由於這些疾病會對患者的生活產生深遠影響，因此神經再生療法的需求至關重要。其次，世界人口正在快速老化。由於老年人更容易患有神經系統疾病，因此對這類療法的需求進一步增加。隨著人們不斷尋求能夠改善生活品質的治療方法，神經再生療法市場預計將會擴張。最後，神經再生領域的研究和開發活動正在蓬勃發展。科學家和研究人員不斷探索新的療法，在促進神經組織修復和再生方面取得了突破性進展。這種持續的創新有望為市場帶來新的療法，從而進一步推動市場成長。總之，疾病負擔沉重、人口老化以及活躍的研究和開發活動預計將共同推動全球神經再生療法市場的發展。

例如，2023年2月6日，生物技術公司百健（Biogen Inc.）和賽格治療（Sage Therapeutics, Inc.）宣布，美國食品藥物管理局（FDA）已接受其新藥認證申請（NDA），用於治療重度憂鬱症（MDD）和產後憂鬱症（PPD）。 Zulanolonone是一種在研藥物，目前正在評估其作為一種速效、每日一次臨床實驗療法，療程為14天，用於治療患有重度憂鬱症（MDD）和產後憂鬱症（PPD）的成年患者。

本報告的主要特點

• 本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
• 此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
• 本節根據各種參數（公司概況、產品系列、主要趨勢、財務表現、策略等）介紹全球神經再生療法市場的主要公司。
• 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
• 《全球神經再生療法市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以透過分析全球神經再生療法市場中使用的各種策略矩陣來促進決策。

目錄

第1章：分析目標與假設

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 神經系統疾病負擔日益加重
  • 高成本和熟練專業人員短缺
  • 安全有效治療的需求很高
• 影響分析
• 主要亮點
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特五力分析
• 企業合併情景

第4章：全球神經再生療法市場：依神經再生療法類型分類（2021-2033 年）

• 幹細胞療法
• 基因治療
• 藥物治療
• 神經刺激療法
• 其他

第5章：全球神經再生療法市場：依適應症分類（2021-2033 年）

• 脊髓損傷
• 中風
• 創傷性腦損傷
• 帕金森氏症
• 阿茲海默症
• 多發性硬化症
• 周邊神經損傷
• 其他

第6章：全球神經再生療法市場：依給藥途徑分類（2021-2033 年）

• 口服藥物
• 注射藥物
• 植入
• 其他

第7章：全球神經再生療法市場：依年齡層分類（2021-2033 年）

• 兒童
• 成人
• 老年人

第8章：全球神經再生療法市場：按最終用戶分類（2021-2033 年）

• 醫院
• 專科診所
• 研究機構
• 復健中心
• 其他

第9章：全球神經再生療法市場：按地區分類（2021-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第10章 競爭格局

• Biogen Inc.
• AstraZeneca PLC
• Pfizer Inc.
• Novartis International AG
• Merck & Co., Inc.
• Sanofi SA
• F. Hoffmann-La Roche Ltd.
• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• Ceregene Inc.
• Lineage Cell Therapeutics, Inc.
• Stemedica Cell Technologies, Inc.
• StemCells Inc.
• Ever Supreme Bio Technology Co., Ltd.
• AbbVie

第11章

• 分析方法
• 關於 Coherent Market Insights

Neuroregeneration Therapy Market is estimated to be valued at USD 16.65 Bn in 2026 and is expected to reach USD 38.44 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.7% from 2026 to 2033.

euroregeneration refers to the process of regenerating or repairing nervous tissue, including neurons, axons, synapses, and glial cells. This process is crucial for replacing damaged tissues due to injury and ensuring long-term functional recovery. It involves the synthesis of new neurons and connections, providing additional resources to substitute the damaged ones. Neuroregeneration is not just about physical recovery; it's also a vital mechanism for maintaining cognitive functions. It plays a significant role in combating memory disorders and abnormalities related to aging. By pharmacologically stimulating neuroregeneration, it's possible to rescue cognitive functions, thereby improving memory and other cognitive abilities. In essence, neuroregeneration is a critical biological process with significant implications for treating various neurological conditions and improving brain health.

Market Dynamics:

The global neuroregeneration therapy market is expected to witness significant growth in the coming years, driven by several key factors. Firstly, the increasing prevalence of neurological disorders, including both central and peripheral nervous system disorders, is creating a high demand for effective and safe treatments. These disorders can have a debilitating impact on patients' lives, making the need for neuroregenerative therapies crucial. Secondly, the world's aging population is growing rapidly. Older individuals are more susceptible to neurological conditions, which further increases the demand for these therapies. As people seek treatments that can improve their quality of life, the market for neuroregeneration therapies is expected to expand. Lastly, there is a surge in research and development activities in the field of neuroregeneration. Scientists and researchers are continually exploring new treatment methods and making breakthroughs in understanding how to stimulate the repair and regrowth of nervous tissue. This ongoing innovation is expected to introduce new therapies to the market, driving further growth. In summary, the combination of a high disease burden, an aging population, and active research and development are set to propel the global neuroregeneration therapy market forward.

For instance, on February 6, 2023, Biogen Inc., a biotechnology company, and Sage Therapeutics, Inc., a biotechnology company, announced that the U.S. Food and Drug Administration (FDA) had accepted the filing of a New Drug Application (NDA) for zuranolone in the treatment of major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is an investigational drug being evaluated as a 14-day, rapid-acting, once-daily, oral treatment in adults with MDD and PPD.

Key features of the study:

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global neuroregeneration therapy market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Biogen Inc., AstraZeneca PLC, Pfizer Inc., Novartis International AG, Merck & Co., Inc., Sanofi S.A., F. Hoffmann-La Roche Ltd., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Ceregene Inc., Stemedica Cell Technologies, Inc., Lineage Cell Therapeutics, Inc., StemCells Inc., Ever Supreme Bio Technology Co., Ltd. and AbbVie
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global neuroregeneration therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuroregeneration therapy market

Detailed Segmentation:

• By Type of Neuroregeneration Therapy (Revenue, USD Bn, 2021 - 2033)
• Stem Cell Therapy
• Gene Therapy
• Pharmacological Therapy
• Neurostimulation Therapy
• Others
• By Indication (Revenue, USD Bn, 2021 - 2033)
• Spinal Cord Injury
• Stroke
• Traumatic Brain Injury
• Parkinson's Disease
• Alzheimer's Disease
• Multiple Sclerosis
• Peripheral Nerve Injury
• Others
• By Mode of Administration (Revenue, USD Bn, 2021 - 2033)
• Oral
• Injectable
• Implantable
• Others
• By Age Group (Revenue, USD Bn, 2021 - 2033)
• Pediatric
• Adult
• Geriatric
• By End User (Revenue, USD Bn, 2021 - 2033)
• Hospitals
• Specialty Clinics
• Research Institutes
• Rehabilitation Centers
• Others
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Company Profiles:
• Biogen Inc.
• AstraZeneca PLC
• Pfizer Inc.
• Novartis International AG
• Merck & Co., Inc.
• Sanofi S.A.
• F.Hoffmann-La Roche Ltd.
• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• Ceregene Inc.
• Lineage Cell Therapeutics, Inc.
• Stemedica Cell Technologies, Inc.
• StemCells Inc.
• Ever Supreme Bio Technology Co., Ltd.
• AbbVie

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type of Neuroregeneration Therapy
  • Market Snippet, By Indication
  • Market Snippet, By Mode of Administration
  • Market Snippet, By Age Group
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Growing burden of neurological disorders
  • High cost and dearth of skilled professionals
  • High demand for safe and effective therapeutics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Neuroregeneration Therapy Market, By Type of Neuroregeneration Therapy, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Stem Cell Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Gene Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Pharmacological Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Neurostimulation Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

5. Global Neuroregeneration Therapy Market, By Indication, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Spinal Cord Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Stroke
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Traumatic Brain Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,( US$ Bn)
• Parkinson's Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Alzheimer's Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Multiple Sclerosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 ,(US$ Bn)
• Peripheral Nerve Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

6. Global Neuroregeneration Therapy Market, By Mode of Administration, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Injectable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Implantable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Other
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

7. Global Neuroregeneration Therapy Market, By Age Group, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Geriatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

8. Global Neuroregeneration Therapy Market, By End User, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Rehabilitation Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

9. Global Neuroregeneration Therapy Market, By Region, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Biogen Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AstraZeneca PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis International AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi S.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F. Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ceregene Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Lineage Cell Therapeutics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Stemedica Cell Technologies, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• StemCells Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ever Supreme Bio Technology Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AbbVie
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Analyst Views

11. Section

• Research Methodology
• About us